Risk of exacerbation of pulmonary comorbidities in patients with rheumatoid arthritis after initiation of abatacept versus TNF inhibitors: A cohort study

Kang Eun Ha; Jin Yinzhu; Desai Rishi J.Liu JunSparks Jeffrey A.Kim Seoyoung C.

首页> 外文期刊>Seminars in Arthritis and Rheumatism >Risk of exacerbation of pulmonary comorbidities in patients with rheumatoid arthritis after initiation of abatacept versus TNF inhibitors: A cohort study

【24h】

Risk of exacerbation of pulmonary comorbidities in patients with rheumatoid arthritis after initiation of abatacept versus TNF inhibitors: A cohort study

机译：Risk of exacerbation of pulmonary comorbidities in patients with rheumatoid arthritis after initiation of abatacept versus TNF inhibitors: A cohort study

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相关主题

摘要

Background: Biologic agents may pose a potential risk for exacerbations of pulmonary comorbidities in rheumatoid arthritis (RA) patients.

著录项

来源
《Seminars in Arthritis and Rheumatism》 |2020年第3期|401-408|共8页
作者
Kang Eun Ha; Jin Yinzhu; Desai Rishi J.Liu JunSparks Jeffrey A.Kim Seoyoung C.;
展开▼
作者单位

Harvard Med Sch, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Suite;

Harvard Med Sch, Div Rheumatol Immunol & Allergy, Brigham & Womens Hosp, Boston, MA 02115 USA;

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类免疫性疾病;
关键词
Rheumatoid arthritis; Pulmonary comorbidity; Interstitial lung disease; Chronic obstructive pulmonary disease; Asthma; Comparative effectiveness research; Biologic DMARD;

Risk of exacerbation of pulmonary comorbidities in patients with rheumatoid arthritis after initiation of abatacept versus TNF inhibitors: A cohort study

摘要

著录项

相关主题

期刊订阅